The group's principal activity is to manufacture medical lasers and related products for use in the treatment of severe coronary artery diseases in a surgical laser procedure. The group's primary product is heart laser system, which is used for transmyocardial revascularization. One of the major customers of the group is edwards. The group's products are sold in the United States, Canada, Germany, Japan and Europe. During the year the group launched European clinical study with an objective of showing an improvement in angina relief, quality relief and other treatment procedure.
